Your browser doesn't support javascript.
loading
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants.
Macchini, Marina; Centonze, Federico; Peretti, Umberto; Orsi, Giulia; Militello, Anna Maria; Valente, Maria Maddalena; Cascinu, Stefano; Reni, Michele.
Afiliação
  • Macchini M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
  • Centonze F; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
  • Peretti U; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
  • Orsi G; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
  • Militello AM; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
  • Valente MM; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
  • Cascinu S; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.
  • Reni M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy; Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy. Electronic address: reni.michele@hsr.it.
Cancer Treat Rev ; 100: 102262, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34418781
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Proteína BRCA1 / Carcinoma Ductal Pancreático / Proteína BRCA2 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Proteína BRCA1 / Carcinoma Ductal Pancreático / Proteína BRCA2 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália